Indication
Diabetic foot infection
A diabetic foot infection refers to a soft tissue or bone infection occurring distal to the malleoli in individuals with diabetes mellitus. Read more about Diabetic foot infection
58 drugs 40 manufacturers
Drugs that treat it
Common Diabetic foot infection therapies.
PIPERACILLIN-TAZOBACTAM (piperacillin sodium/tazobactam sodium)
PIPERACILLIN-TAZOBACTAM (piperacillin sodium/tazobactam sodium)
PIPERACILLIN-TAZOBACTAM (piperacillin sodium/tazobactam sodium)
PIPERACILLIN-TAZOBACTAM (piperacillin sodium/tazobactam sodium)
PIPERACILLIN-TAZOBACTAM (piperacillin sodium/tazobactam sodium)
ZOSYN (piperacillin and tazobactam in dextrose, iso-osmotic)
IMIPENEM-CILASTATIN SODIUM (imipenem/cilastatin sodium)
IMIPENEM-CILASTATIN SODIUM (imipenem/cilastatin sodium)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA diabetic foot infection refers to a soft tissue or bone infection occurring distal to the malleoli in individuals with diabetes mellitus.
It typically develops when microbial pathogens invade the skin through a break in the cutaneous barrier, most commonly a chronic neuropathic or neuroischemic ulceration.
Pathophysiologically driven by peripheral neuropathy, peripheral artery disease, and impaired immune defenses, the condition is clinically defined by purulent drainage or at least two classic signs of inflammation, such as erythema, warmth, tenderness, pain, or induration.
Clinical severity ranges from superficial cellulitis to deep-tissue abscesses, necrotizing fasciitis, and osteomyelitis, often progressing to limb-threatening complications or systemic toxicity if left unchecked.
- nih.gov
A diabetic foot infection refers to a soft tissue or bone infection occurring distal to the malleoli in individuals with diabetes mellitus
- nih.gov
A diabetic foot infection refers to a soft tissue or bone infection occurring distal to the malleoli in individuals with diabetes mellitus Pathophysiologically driven by peripheral neuropathy, peripheral artery disease, and impaired immune defenses, the condition is clinically defined by purulent drainage or at least two classic signs of inflammation, such as erythema, warmth, tenderness, pain, or induration Clinical severity ranges from superficial cellulitis to deep-tissue abscesses, necrotizi...
- nih.gov
It typically develops when microbial pathogens invade the skin through a break in the cutaneous barrier, most commonly a chronic neuropathic or neuroischemic ulceration Clinical severity ranges from superficial cellulitis to deep-tissue abscesses, necrotizing fasciitis, and osteomyelitis, often progressing to limb-threatening complications or systemic toxicity if left unchecked
- nih.gov
It typically develops when microbial pathogens invade the skin through a break in the cutaneous barrier, most commonly a chronic neuropathic or neuroischemic ulceration Pathophysiologically driven by peripheral neuropathy, peripheral artery disease, and impaired immune defenses, the condition is clinically defined by purulent drainage or at least two classic signs of inflammation, such as erythema, warmth, tenderness, pain, or induration
- nebraskamed.com
It typically develops when microbial pathogens invade the skin through a break in the cutaneous barrier, most commonly a chronic neuropathic or neuroischemic ulceration Pathophysiologically driven by peripheral neuropathy, peripheral artery disease, and impaired immune defenses, the condition is clinically defined by purulent drainage or at least two classic signs of inflammation, such as erythema, warmth, tenderness, pain, or induration
Personalize your experience
Follow Diabetic foot infection and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.